Benznidazole
CAS No. 22994-85-0
Benznidazole( Ro 71051 | Benznidazol | Ro 07-1051 | Radanil )
Catalog No. M19879 CAS No. 22994-85-0
Benznidazole has an antiprotozoal activity by interfering with parasite protein biosynthesis influencing cytokines production and stimulating host phagocytosis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 33 | In Stock |
|
| 25MG | 29 | In Stock |
|
| 50MG | 45 | In Stock |
|
| 100MG | 60 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBenznidazole
-
NoteResearch use only, not for human use.
-
Brief DescriptionBenznidazole has an antiprotozoal activity by interfering with parasite protein biosynthesis influencing cytokines production and stimulating host phagocytosis.
-
DescriptionBenznidazole has an antiprotozoal activity by interfering with parasite protein biosynthesis influencing cytokines production and stimulating host phagocytosis.(In Vivo):Benznidazole (100 mg/kg/day, p.o., 30 days) produces a decrease in electrocardiographic alterations, fewer modifications in the affinity and density of cardiac-receptors, and few isolated areas of fibrosis in the heart, in mice infected with Trypanosoma cruzi Tulahuen strain or SGO-Z12 isolate and treated at 180 days post infection (p.i.) (i.e. chronic phase) with Benznidazole.
-
In Vitro——
-
In VivoBenznidazole (100 mg/kg/day, p.o., 30 days) produces a decrease in electrocardiographic alterations, fewer modifications in the affinity and density of cardiac-receptors, and few isolated areas of fibrosis in the heart, inmice infected with Trypanosoma cruzi Tulahuen strain or SGO-Z12 isolate and treated at 180 days post infection (p.i.) (i.e. chronic phase) with Benznidazole. Animal Model:Mice infected with Trypanosoma cruzi Tulahuen strain or SGO-Z12 Dosage:100 mg/kg/day Administration:Orally for 30 daysResult:Produced a decrease in electrocardiographic alterations, fewer modifications in the affinity and density of cardiac-receptors, and few isolated areas of fibrosis in the heart.
-
SynonymsRo 71051 | Benznidazol | Ro 07-1051 | Radanil
-
PathwayMicrobiology/Virology
-
TargetAntibiotic
-
Recptorantiprotozoal
-
Research AreaInflammation/Immunology
-
IndicationChagas disease
Chemical Information
-
CAS Number22994-85-0
-
Formula Weight260.25
-
Molecular FormulaC12H12N4O3
-
Purity>98% (HPLC)
-
SolubilityMethanol: 50 mg/mL;DMSO: 30 mg/mL
-
SMILES[O-][N+](=O)c1nccn1CC(=O)NCc1ccccc1
-
Chemical Name2-Nitro-N-(phenylmethyl)-1H-imidazole-1-acetamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Calvo KL et al. Benznidazole modulates cell proliferation in acute leukemia cells. Immunopharmacol Immunotoxicol. 2013 Aug;35(4):478-86.
molnova catalog
related products
-
Virginiamycin S1
Virginiamycin S1 is a streptozotocin B antibiotic produced by Streptomyces verticillioides, which has antibacterial activity by inhibiting bacterial protein synthesis at the level of aminoacyl-tRNA binding and peptide bond formation.
-
Gastric mucin
Gastric mucin is a large glycoprotein which is thought to play a major role in the protection of the gastrointestinal tract from acid, proteases, pathogenic microorganisms, and mechanical trauma.
-
Phleomycin D1
Phleomycin D1 (PLM D1), a glycopeptide antibiotic in the Bleomycin/Phleomycin family, induces cell death by binding to and cleaving DNA .
Cart
sales@molnova.com